Bacterial infections
Inhibits bacterial DNA-gyrase, blocking DNA replication and halting bacterial growth
500 mg tablets, manufactured under strict quality control standards
Produced at our US FDA approved facility in Baddi, Himachal Pradesh
Urinary tract infections, respiratory infections, typhoid fever, skin infections
Trusted by pharma partners and distributors across 90+ countries
Manufactured under WHO-GMP compliant processes at our US FDA approved facility in Baddi, Himachal Pradesh.
Rigorous quality control at every stage ensures reliable purity and potency across every batch produced.
Trusted by pharmaceutical partners and distributors across 90+ countries worldwide.
Ciprofloxacin is a broad-spectrum fluoroquinolone antibiotic widely used across primary and hospital care for treating bacterial infections. It works by inhibiting bacterial DNA-gyrase, an enzyme essential for DNA replication and repair, preventing the relaxation of supercoiled DNA and promoting breakage of double-stranded DNA within the bacterial cell — effectively halting bacterial growth and multiplication. Its broad-spectrum activity against gram-negative and select gram-positive organisms makes it an effective treatment for urinary tract infections, respiratory tract infections, typhoid fever, and skin and soft tissue infections. Pinnacle Life Science manufactures Ciprofloxacin tablets at its US FDA approved facility in Baddi, Himachal Pradesh, following WHO-GMP compliant processes to ensure consistent quality, purity, and potency across every batch. As a subsidiary of Aarti Drugs Ltd, Pinnacle combines decades of pharmaceutical manufacturing expertise with modern automation and rigorous quality control, making it a trusted partner for pharmaceutical distributors and companies sourcing reliable antibiotic formulations for regulated and semi-regulated markets across 90+ countries.